AMA Ed Hub Logo

Get fast-track DEA training from AMA Ed Hub™
Red JAMA Logo

Learn more on the overdose epidemic from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on the overdose epidemic from PolicyFinder
AMA in Action: Ending the overdose epidemic

End the Epidemic website
Clear Search
Pharmacist holding a packaged prescription
·
6 Min Read

When arbitrary policies collide with patient care

Correcting a national pharmacy chain’s misinterpretation of CDC opioid-prescribing guidelines turned into a six-month headache for an Illinois doctor.

Behavioral Health
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of July 12, 2021

In the news: Johnson & Johnson vaccine and Guillain-Barré, COVID infections doubled in three weeks, CDC reports 29% increase in overdose deaths, additional COVID shots for immunocompromised.

Publications & Newsletters
·
2 Min Read

Rhode Island is first state to support pilot harm reduction center

AMA strongly supports efforts to reduce drug-related overdose and death.

Press Releases
Open doors of a cell in a correctional facility or prison.
·
4 Min Read

Require access to Rx for opioid-use disorder in prisons, jails

Delegates seek to ensure that evidence-based treatment for substance-use disorders, along with social support, is available in correctional facilities and upon release.

Population Health
Naloxone spray
·
3 Min Read

Biden administration boosts access to overdose prevention, treatment

The drug-overdose epidemic continues during the COVID-19 pandemic, but steps are being taken that will save lives and enhance access to treatment.

Behavioral Health
·
6 Min Read

May 7, 2021: State Advocacy Update

Washington is the first state to require PPE reimbursement and more in the latest State Advocacy Update.

Advocacy Update
Pedestrians crossing the street
·
4 Min Read

Removing stigma, advancing evidence-based care at Mount Sinai

Learn about an innovative primary care program at the New York hospital that helps people with opioid-use disorder get the care they need.

Behavioral Health
·
1 Min Read

AMA statement on FDA decision on naloxone nasal

AMA commends FDA’s approval of a higher dose naloxone hydrochloride nasal spray product to treat opioid overdose.

Press Releases
·
4 Min Read

8 keys to end the nation’s drug-overdose epidemic

The CDC is reporting a record-breaking annual toll of nearly 90,000 U.S. overdose deaths. Learn about the policy steps needed to stem the tide.

Behavioral Health